臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wen fang cheng"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 301-325 / 485 (共20頁)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-02-06T05:22:04Z	Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma	WEN-FANG CHENG; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; Chen C.-A.; Chen C.-A.;Chien C.-L.;Huang C.-T.;Lin H.-W.;Chang M.-C.;WEN-FANG CHENG;Chen Y.-L.; Chen Y.-L.; WEN-FANG CHENG; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; Chen C.-A.; Chen Y.-L.
臺大學術典藏	2020-02-06T05:22:03Z	Fusion Protein Vaccines Targeting Two Tumor Antigens Generate Synergistic Anti-Tumor Effects	Chen C.-A.;Chen Y.-Y.;Liao C.-W.;Jen Y.-W.;Sun W.-Z.;Chang M.-C.;WEN-FANG CHENG; WEN-FANG CHENG; Chang M.-C.; Sun W.-Z.; Jen Y.-W.; Liao C.-W.; Chen Y.-Y.; Chen C.-A.; WEN-FANG CHENG; Chang M.-C.; Sun W.-Z.; Jen Y.-W.; Liao C.-W.; Chen Y.-Y.; Chen C.-A.
臺大學術典藏	2020-02-06T05:22:03Z	Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation	Iafrate A.J.;Chand V.K.;Lobmeyer M.T.;Le Maulf F.;Robohn M.;Su W.-C.;WEN-FANG CHENG;Lenz H.-J.;Becerra C.R.;Cohen S.M.;Shapiro G.I.;Kwak E.L.; Kwak E.L.; Shapiro G.I.; Cohen S.M.; Becerra C.R.; Lenz H.-J.; WEN-FANG CHENG; Su W.-C.; Robohn M.; Le Maulf F.; Lobmeyer M.T.; Chand V.K.; Iafrate A.J.; Kwak E.L.; Shapiro G.I.; Cohen S.M.; Becerra C.R.; Lenz H.-J.; WEN-FANG CHENG; Su W.-C.; Robohn M.; Le Maulf F.; Lobmeyer M.T.; Chand V.K.; Iafrate A.J.
臺大學術典藏	2020-02-06T05:22:03Z	High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions	Chen C.-A.;Lin M.-C.;Hsieh C.-Y.;Chang M.-C.;Chen Y.-L.;WEN-FANG CHENG;Chiang Y.-C.; Chiang Y.-C.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Hsieh C.-Y.; Lin M.-C.; Chen C.-A.; Chiang Y.-C.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Hsieh C.-Y.; Lin M.-C.; Chen C.-A.
臺大學術典藏	2020-02-06T05:22:02Z	Superficial angiomyxoma on the vulva of an adolescent	WEN-FANG CHENG;Chen C.-A.;Liau J.-Y.;Chen Y.-L.;Lee C.-C.; Lee C.-C.; Chen Y.-L.; Liau J.-Y.; Chen C.-A.; WEN-FANG CHENG; Lee C.-C.; Chen Y.-L.; Liau J.-Y.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:22:02Z	Cell-type-dependent associations of heme oxygenase-1 GT-repeat polymorphisms with the cancer risk in arsenic-exposed individuals: A preliminary report	Lee T.C.;Chiou H.-Y.;Chen C.-J.;Hsu L.-I.;WEN-FANG CHENG;Wu M.M.; Wu M.M.; WEN-FANG CHENG; Hsu L.-I.; Chen C.-J.; Chiou H.-Y.; Lee T.C.; Wu M.M.; WEN-FANG CHENG; Hsu L.-I.; Chen C.-J.; Chiou H.-Y.; Lee T.C.
臺大學術典藏	2020-02-06T05:22:02Z	Circulating IGF system and treatment outcome in epithelial ovarian cancer	Chou C.-Y.;Hsu K.-F.;Cheng Y.-M.;Wu Y.-P.;WEN-FANG CHENG;Huang Y.-F.; Huang Y.-F.; WEN-FANG CHENG; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y.; Huang Y.-F.; WEN-FANG CHENG; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y.
臺大學術典藏	2020-02-06T05:22:02Z	Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan	Lin M.-C.; You S.-L.; WEN-FANG CHENG; Lai M.-S.; Hsu T.-H.; Chiang C.-J.; Chen C.-A.; Chiang Y.-C.; Lai M.-S.; WEN-FANG CHENG; You S.-L.; Lin M.-C.; Hsu T.-H.; Chiang C.-J.; Lai M.-S.;WEN-FANG CHENG;You S.-L.;Lin M.-C.;Hsu T.-H.;Chiang C.-J.;Chen C.-A.;Chiang Y.-C.; Chiang Y.-C.; Chen C.-A.
臺大學術典藏	2020-02-06T05:22:01Z	Solitary primary peritoneal carcinoma arising from the omentum	WEN-FANG CHENG;Chen C.-A.;Wu C.-J.;Lin M.-C.;Tai Y.-J.; Tai Y.-J.; Lin M.-C.; Wu C.-J.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-J.; Lin M.-C.; Wu C.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:59Z	Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas	WEN-FANG CHENG;Chou C.-Y.;Cheng Y.-Y.K.;You S.-L.;Hu Y.-H.;Chang M.-C.;Chiang Y.-C.;Chen C.-A.; Chen C.-A.; Chiang Y.-C.; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG; Chen C.-A.; Chiang Y.-C.; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:59Z	Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma	WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Chen T.-C.;Fu C.-F.;Chang M.-C.;Chang C.-F.;Lin H.-W.;Chiang Y.-C.; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:59Z	Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFN�^	Roden R.B.S.; Wu T.-C.; Trimble C.L.; Hung C.-F.; Soong R.-S.; Song L.; Trieu J.; Knoff J.; He L.; Tsai Y.-C.; Huh W.; Chang Y.-N.; WEN-FANG CHENG; Roden R.B.S.; Wu T.-C.; Trimble C.L.; Hung C.-F.; Hung C.-F.;Trimble C.L.;Wu T.-C.;Roden R.B.S.;WEN-FANG CHENG;Chang Y.-N.;Huh W.;Tsai Y.-C.;He L.;Knoff J.;Trieu J.;Song L.;Soong R.-S.; Soong R.-S.; Song L.; Trieu J.; Knoff J.; He L.; Tsai Y.-C.; Huh W.; Chang Y.-N.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:58Z	Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients	WEN-FANG CHENG;Chen C.-A.;Kuo K.-T.;Huang H.-D.;Tang Y.-C.;Huang C.-T.;Huang W.-Y.;Chang M.-C.;Huang C.-Y.; Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; Kuo K.-T.; Chen C.-A.; WEN-FANG CHENG; Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; Kuo K.-T.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:58Z	Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation	WEN-FANG CHENG;Chen C.-A.;Chen T.-C.;Chen Y.-L.;Chang M.-C.;Huang C.-T.; Huang C.-T.; Chang M.-C.; Chen Y.-L.; Chen T.-C.; Chen C.-A.; WEN-FANG CHENG; Huang C.-T.; Chang M.-C.; Chen Y.-L.; Chen T.-C.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:58Z	Molecular alterations in endometrial and ovarian clear cell carcinomas: Clinical impacts of telomerase reverse transcriptase promoter mutation	Kuo K.-T.;Lin M.-C.;Chen C.-A.;WEN-FANG CHENG;Chiang Y.-C.;Huang H.-N.; Huang H.-N.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A.; Lin M.-C.; Kuo K.-T.; Huang H.-N.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A.; Lin M.-C.; Kuo K.-T.
臺大學術典藏	2020-02-06T05:21:58Z	IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients	WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Huang C.-T.;Lin H.-W.;Chang M.-C.;Chou C.-Y.;Chen Y.-L.; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:56Z	Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis	WEN-FANG CHENG;Chang S.-F.;Huang S.-H.;Hsiao C.-C.;Shih D.T.-B.;Ho C.-M.; Ho C.-M.; Shih D.T.-B.; Hsiao C.-C.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG; Ho C.-M.; Shih D.T.-B.; Hsiao C.-C.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:56Z	Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway	WEN-FANG CHENG;Chang S.-F.;Huang S.-H.;Huang C.-J.;Ho C.-M.; Ho C.-M.; Huang C.-J.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG; Ho C.-M.; Huang C.-J.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:56Z	The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia	Lai M.-S.;Yang J.C.H.;Cheng A.-L.;WEN-FANG CHENG;Hsu C.;Shao Y.-Y.;Yang Y.-Y.;Lai C.-L.;Shau W.-Y.;Kuo R.;Lin Z.-Z.;Kuo H.-Y.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏	2020-02-06T05:21:56Z	Establishment of a New Ovarian Cancer Cell Line CA5171	Chen C.-A.;Hsieh C.-Y.;Lin H.-P.;Kuo K.-T.;Lu T.-P.;Chang M.-C.;WEN-FANG CHENG;Chiang Y.-C.; Chiang Y.-C.; WEN-FANG CHENG; Chang M.-C.; Lu T.-P.; Kuo K.-T.; Lin H.-P.; Hsieh C.-Y.; Chen C.-A.; Chiang Y.-C.; WEN-FANG CHENG; Chang M.-C.; Lu T.-P.; Kuo K.-T.; Lin H.-P.; Hsieh C.-Y.; Chen C.-A.
臺大學術典藏	2020-02-06T05:21:55Z	Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine	Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; WEN-FANG CHENG; Sun W.-Z.; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; WEN-FANG CHENG; Sun W.-Z.; Sun W.-Z.;WEN-FANG CHENG;Chen C.-A.;Jen Y.-W.;Cheng Y.-J.;Chiang Y.-C.;Chen Y.-L.;Chang M.-C.; Chang M.-C.
臺大學術典藏	2020-02-06T05:21:55Z	Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator	WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Tang Y.-C.;Chen T.-C.;Chiang Y.-C.;Chen Y.-L.;Chang M.-C.; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:54Z	Metronomic chemotherapy and immunotherapy in cancer treatment	WEN-FANG CHENG; WEN-FANG CHENG;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.
臺大學術典藏	2020-02-06T05:21:54Z	Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study	Taiwan Cervical Cancer Prevention Surveillance Center;Chen C.-A.;Lai M.-S.;WEN-FANG CHENG;You S.-L.;Chiang C.-J.;Hsieh S.-F.;Chen Y.-Y.;Chiang Y.-C.; Chiang Y.-C.; Chen Y.-Y.; Hsieh S.-F.; Chiang C.-J.; You S.-L.; WEN-FANG CHENG; Lai M.-S.; Chen C.-A.; Taiwan Cervical Cancer Prevention Surveillance Center; Chiang Y.-C.; Chen Y.-Y.; Hsieh S.-F.; Chiang C.-J.; You S.-L.; WEN-FANG CHENG; Lai M.-S.; Chen C.-A.; Taiwan Cervical Cancer Prevention Surveillance Center
臺大學術典藏	2020-02-06T05:21:53Z	Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies	Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Chiang Y.-C.;Chen Y.-Y.;Lee S.-P.;Hsu H.-C.;Tai Y.-J.;Tai Y.-H.; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P.

顯示項目 301-325 / 485 (共20頁)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52566394 線上人數 : 814 教育部委託研究計畫計畫執行:國立臺灣大學圖書館